Results 101 to 110 of about 178,801 (195)

Therapeutic effects of sphingosine kinase inhibitor N,N-dimethylsphingosine (DMS) in experimental chronic Chagas disease cardiomyopathy

Scientific Reports, 2017
Chagas disease cardiomyopathy is a parasite-driven inflammatory disease to which there are no effective treatments. Here we evaluated the therapeutic potential of N,N-dimethylsphingosine(DMS), which blocks the production of sphingosine-1-phosphate(S1P ...
Juliana Fraga Vasconcelos, Cássio Santana Meira, Daniela Nascimento Silva, Carolina Kymie Vasques Nonaka, Pâmela Santana Daltro, Simone Garcia Macambira, Pablo Daniel Domizi, Valéria Matos Borges, Ricardo Ribeiro-dos-Santos, Bruno Solano de Freitas Souza, Milena Botelho Pereira Soares   +10 more
doaj   +1 more source

ISEV2026 Abstract Book

Journal of Extracellular Vesicles, Volume 15, Issue S1, June 2026.
wiley   +1 more source

Comparação do desfecho entre a cardiopatia chagásica e a miocardiopatia dilatada idiopática Comparison of outcome between Chagas cardiomyopathy and idiopathic dilated cardiomyopathy

Arquivos Brasileiros de Cardiologia, 2011
FUNDAMENTO: Pouco se sabe sobre o desfecho dos pacientes com cardiopatia chagásica, em comparação aos pacientes com miocardiopatia dilatada idiopática na era contemporânea. OBJETIVO: Comparar o desfecho dos pacientes chagásicos com insuficiência cardíaca
Amanda Pires Barbosa, Augusto Cardinalli Neto, Ana Paula Otaviano, Bianca Faria Rocha, Reinaldo Bulgarelli Bestetti   +4 more
doaj  

Comparison of blood culture, T. cruzi genotype and parasite load in patients with different degrees of chronic Chagas disease cardiomyopathy.

, 2018
Comparison of blood culture, T. cruzi genotype and parasite load in patients with different degrees of chronic Chagas disease cardiomyopathy.
Lúcia Maria C. Galvão (6029264), Constança Britto (294223), Egler Chiari (16214), Daniella Alchaar D’Ávila (6029261), Giovane R. Sousa (3694537), Otacilio C. Moreira (2174402)   +5 more
core   +1 more source

Benznidazole for Chronic Chagas’ Cardiomyopathy

New England Journal of Medicine, 2016
Hamers, Raph L., van Gool, Tom, Goorhuis, Abraham   +2 more
openaire   +6 more sources

REACTIVATION OF CHAGAS DISEASE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT: CASE SERIES

Brazilian Journal of Infectious Diseases
Chagas disease, caused by Trypanosoma cruzi, remains an important public health problem in the Americas. Although the most prevalent chronic form is cardiac, central nervous system reactivation is rare but severe, particularly in immunosuppressed ...
Clara dos Reis Aguiar, Natália Soares Albuquerque, Claudia Murta de Oliveira, Isabela Rocha de Castro, Leandro Curi de Lima e Sousa   +4 more
doaj   +1 more source

Chagas, a Cardiomyopathy Emerging from Obscurity [PDF]

European Journal of Heart Failure, 2015
Westenbrink, B. Daan, Kingma, J. Herre
openaire   +3 more sources

Dilated cardiomyopathy in childhood [PDF]

, 2000
Dilated Cardiomyopathy is an uncommon disease in children but morbidity and mortality in affected patients are high. This review discuses clinical presentation, diagnosis, medical management and prognosis of the condition, with an emphasis on recent ...
Franklin, O.M.
core  

The Cardiac Autoantibody Fingerprint of Chagas Cardiomyopathy: Towards Accessible Risk Stratification. [PDF]

JACC Basic Transl Sci
Sattler S.
europepmc   +1 more source

Identifying Cardiac Autoantibody Biomarkers that Predict the Severity of Chagas Cardiomyopathy. [PDF]

JACC Basic Transl Sci
Ribeiro H, Dmitriev A, Rosa Neta AP, Fatah M, Chatterjee D, Campos de Oliveira L, Albrecht FC, Lin Wang HT, Gomes JAS, Woźniak O, Borowiec K, Biernacka EK, Jácome da Câmara AC, Sacilotto L, Darrieux FCDC, Scanavacca MI, Krieger JE, Galvão LMDC, Dutra W, Pinho Ribeiro AL, Cunha-Neto E, Pereira Nunes MC, Sabino EC, Cestari I, Luchessi AD, Silbiger VN, Hamilton RM.   +26 more
europepmc   +1 more source